Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
MedTech
Acquisitive Boston Scientific sees growth rate ease in Q3
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year.
Ben Adams
Oct 22, 2025 10:05am
Thermo Fisher sales jump 5% in Q3 amid new launches, approvals
Oct 22, 2025 9:20am
Quest Diagnostics, Danaher see Q3 sales bump
Oct 21, 2025 11:00am
Abbott device growth offsets diagnostics sales slide in Q3
Oct 15, 2025 11:00am
AbbVie flags $2.7B R&D hit to brace investors for lower profit
Oct 6, 2025 3:27am
IQVIA unveils AI suite for managing clinical trial finances
Sep 10, 2025 2:44pm
